Hikma Pharmaceutical
HIK
Delayed London Stock Exchange - 06/27 05:35:18 pm
1516GBp
-4.77%
Prev.1592.0000
Open1582.0000
High1582.0000
Low1514.0000
Volume409 718
Last news
Financials
Sales 2017 2 078 M
EBIT 2017 415 M
R. net 2017 222 M
Debt 2017 475 M
Rend. 2017 1,53%
P/E ratio 2017 21,58
P/E ratio 2018 15,93
EV / Sales 2017 2,57x
EV / Sales 2018 2,31x
Capitalization 4 870 M
Company
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products.It operates through the following segments: Branded, Injectables, Generics, and Others.The Branded segment offers selling of branded generics and in-licensed...
Sector :
Pharmaceuticals - NEC
Calendar : 2017-08-17 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance1 6731 9371 973
Spread/Res.-9,4%-22%-23%
Spread/Supp.-4,7%-4,7%-4,7%
Support1 5901 5901 590